“…Similar to Carbicarb, it does not generate CO 2 , There is no sodium load resulting from THAM, but its use has been discouraged based on possible deleterious side effects such as hypotension, hypoglycemia, and marked shifts to the left of the hemoglobin dissociation curve (190). However, two recent animal studies failed to substantiate adverse effects of continuous THAM infusion in the treatment of respiratory acidosis (190,191).Perhaps the clinical usefulness of THAM should be reevaluated. Should adverse consequences of acidosis, such as intolerable pulmonary hypertension or the incessant need to increase adrenergic support, occur and remain unresponsive to buffer therapy, one might be led to increase ventilation and settle for airway pressures higher than the ideal goal.…”